【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the World Market for Antithrombotic Drugs
1.2 Why Should You Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
1.10 Glossary of Abbreviations
2. Blood Clotting: Mechanisms, Disorders and Current Treatments
2.1 Understanding Haemostasis and Coagulation
2.2 What is Thrombosis
2.3 Complications of Thrombosis
2.3.1 Pulmonary Embolism: A Thrombus Blocking Blood Supply to the Lungs
2.3.2 Stroke Results From Blockage of Blood Flow to the Brain
2.3.3 Acute Coronary Syndrome (ACS): Blockage of Blood Supply to the Heart
2.4 Antithrombotic Drug Treatment
3. Antithrombotic Drugs: World Market 2015-2025
3.1 The World Antithrombotic Drug Market in 2013 and 2014
3.2 The World Antithrombotic Drug Market: Overarching Revenue Forecast 2014-2025
3.3 Driving and Restraining Forces Affecting the Antithrombotic Drugs Market
3.3.1 An Increasing Patient Population Drives Market Growth
3.3.2 Intense Competition from Generics Threatens to Restrain the Market
3.4 The Antithrombotic Drug Market by Therapeutic Class: Revenue and Market Share Predictions, 2019 and 2025
3.5 The Future of the World Market for Antithrombotic Drugs by Therapeutic Class: Grouped Revenue Forecasts, 2014-2025
3.6 Anticoagulant Drugs: Leading the Market from 2014 Onwards
3.6.1 Direct Factor Xa Inhibitors: A Novel Therapeutic Class With Great Potential
3.6.2 Heparins: Second-Leading Anticoagulant Class in 2013
3.6.3 Direct Thrombin Inhibitors Achieved High Growth in 2013 and 2014
3.6.4 Vitamin K Antagonists Have Led the Anticoagulant Drug Market for 60 Years
3.7 Antiplatelet Drugs Were the Second-Leading Therapeutic Class in 2014
3.8 Fibrinolytics Will Continue to be a Staple of the Antithrombotic Drug Market
4. Leading Products in the Market: Prospects, 2015-2025
4.1 Plavix and Lovenox Remain the Market Leaders in 2012 and 2013, Despite Generic Competition
4.2 The Leading Antithrombotic Drugs: Comparison of Revenue and Market Share, 2019 and 2025
4.3 Which Medicines Will Achieve the Highest Rate of Growth to 2025?
4.4 Plavix Faces Competition from Generics, So What Does the Future Hold?
4.4.1 Branded Competition for Plavix?
4.5 Lovenox: Biosimilar Competition in the EU is Expected
4.6 Xarelto: Leading Antithrombotic of 2014
4.7 Pradaxa’s Continued Growth in 2014
4.8 Activase Leads the Fibrinolytics Market, With Little Competition
4.9 Effient Competes with Brilinta/Brilique as well as Generic Competition for Plavix
4.10 Aspirin Cardio: The Most Lucrative Version of Acetylsalicylic Acid
4.11 Angiomax/Angiox is Losing Share of the Direct Thrombin Inhibitors Market to Pradaxa
4.12 Pletal Faces Generic Competition and Restrictions on Use in Europe
4.13 Aggrenox/Asasantin to Face Generic Competition Earlier Than Expected in the US
4.14 Sandoz’s Enoxaparin Sodium: Revenue Forecast 2014-2025
4.15 Fragmin Faces Rivalry from Generic Competition to Lovenox
4.16 Brilinta/Brilique: Investigation Closed in 2014
4.17 Eliquis: Will Late Entry to the Market Affect Uptake?
4.18 Arixtra: Aspen Pharmacare Has Acquired Worldwide Rights from GSK
4.19 New Approvals in the Antithrombotic Drugs Market, 2014
4.19.1 Zontivity: The Newest Approval in Antithrombotics
4.19.2 Lixiana/Savaysa: Expansion into Other Regional Markets
5. Leading National Markets, 2014-2025
5.1 Which Were the Leading National Markets for Sales of Antithrombotic Drugs in 2013 and 2014?
5.2 The Leading National Markets for Antithrombotic Drugs: Comparison of Revenues and Market Shares, 2019 and 2025
5.3 Which National Markets Will Grow Fastest to 2025?
5.4 The US: Dominating the Antithrombotic Drug Market Through 2014-2025
5.5 The EU5: Are the Guidelines for Approval of Biosimilar LMWHs Set to Change?
5.5.1 Germany Leads the EU5
5.5.2 France: Healthcare System Reform Will Inhibit Sales Growth?
5.5.3 UK: Pharmaceutical Price Regulation Scheme
5.5.4 Italy’s Healthcare System – Advantages Conducive to Business
5.5.5 Spain: Reductions in Governmental Healthcare Spending Will Restrict Growth
5.6 Japan: The Aging Population Will Stimulate Demand for Antithrombotic Drugs from 2015-2025
5.7 Chinese Antithrombotic Drug Market Will Capture Market Share
5.8 Brazilian Antithrombotic Drug Market 2015-2025: Strong Growth as Universal Healthcare Coverage is Expanded
5.9 Indian Antithrombotic Drug Market – Limited by Governmental Healthcare Spending?
5.10 Russian Antithrombotic Drug Market: Limited Healthcare Funding Will Prevent Expansive Growth
6. Antithrombotic Drug Development: R&D Pipeline
6.1 The R&D Pipeline for Antithrombotic Drugs: Overview
6.2 The Antiplatelet Drug R&D Pipeline in 2014
6.2.1 Pozen is Seeking a Strategic Partner for its Antiplatelet Drug, PA32540
6.2.2 The Medicines Company’s Kangrexel (Cangrelor) Awaits Approval
6.3 The R&D Pipeline for Anticoagulants, 2014
6.3.1 Heparins: Little R&D Activity in 2014
6.3.1.1 Will Development of Momenta’s Adomiparin Continue?
6.3.1.2 The Discontinuation of Semuloparin
6.3.2 The Vitamin K Antagonist Pipeline: One Product in Development in 2014
6.3.3 Many Development Direct Thrombin Inhibitors Have Been Discontinued
6.3.4 The Direct Factor Xa Inhibitor Pipeline: Only Two Compounds Remain
6.3.5 Portola Pharmaceuticals’ Betrixaban
6.3.6 Sanofi Has Apparently Discontinued Development of Otamixaban
6.4 The Fibrinolytics R&D Pipeline, 2014
6.4.1 Lundbeck’s Desmoteplase: Failed to Meet Primary Endpoint in Phase III
6.4.2 Bharat Biotech and ThromboGenics’ THR-100
6.5 The R&D Pipeline for Other Antithrombotic Drugs, 2014
6.5.1 Kyowa Hakko Kirin’s KW-3357: Filed in Japan, 2014
6.5.2 Asahi Kasei Pharma America’s ART 123
6.5.3 Regado Biosciences/Tobira Therapeutics is Developing an Anticoagulation System with an Antidote
6.5.4 Isis Pharmaceuticals’ ISIS-FXI Rx
7. Leading Companies in the Antithrombotic Drug Market
7.1 Leading Antithrombotic Drug Manufacturers in 2014
7.2 Sanofi Leads the Market, but is its Position Under Threat?
7.3 Boehringer Ingelheim Captures Market Share
7.4 Bayer Markets Two Antithrombotic Drugs
7.5 Johnson & Johnson Can Achieve Success with a Limited Product Portfolio
7.6 Genentech Will Retain Market Share
7.7 The Medicines Company’s Position Will be Bolstered by the Launch of its New Drug
7.8 Eli Lilly: Market Position is Dependent on Success of Effient
7.9 Otsuka: A Limited Antithrombotic Drug Portfolio
7.10 Pfizer: A Gradually Increasing Share of the Market
7.11 Bristol-Myers Squibb Had a Dramatic Loss of Market Share in 2013
8. Qualitative Analysis of the Antithrombotic Drugs Market, 2015
8.1 The Strengths and Weaknesses of the Antithrombotic Drug Market in 2015
8.1.1 Thrombotic Disease: Management Rather Than Cure
8.1.2 The Lack of Antidotes for the Novel Oral Anticoagulants Restricts the Market
8.2 Opportunities and Threats Facing the Market 2015-2025
8.2.1 Rising Disease Prevalence Creates Opportunities in the Market
8.2.2 Further Development of Existing Drugs
8.2.3 High Demand for Antidotes to the Novel Oral Anticoagulants
8.2.4 The Threat of Generic Competition
8.2.5 High Level of Competition is a Threat to New Entrants – What Can Developers Do?
8.2.6 High Risk of Investment in New Drug Development
8.2.7 Healthcare Budget Pressures Threaten Drug Launches and Prices in Europe
8.3 Social, Technological, Economic and Political Factors Influencing the Antithrombotic Drug Market 2015-2025
8.3.1 Social Factors: An Expanding Patient Population and Increasing Awareness
8.3.2 Technological Advances Encourage the Development of Improved Treatment Options
8.3.3 Economic Factors
8.3.3.1 Cost Cutting in the EU and the US
8.3.3.2 Free Trade within the EU Presents Challenges
8.3.4 Political Factors: Will the Affordable Care Act Increase Patient Access to Antithrombotic Drugs?
9. Research Interviews
9.1 Interview with Dr Sanjay Bhanot, PhD, Vice President of Clinical Development and Translational Medicine, Isis Pharmaceuticals, Inc.
9.1.1 Isis Pharmaceuticals Antithrombotic Drugs Pipeline
9.1.2 ISIS-FXIRx Phase II Results
9.1.3 Trends in the Antithrombotic Drug Market, 2015-2025
9.2 Interview with Dr Marcelo A. Lima, Research Fellow and Professor of Molecular Biology, Department of Biochemistry, Universidade Federal de São Paulo, Brazil
9.2.1 Recent Research on a Novel Heparin-Like Compound Derived From Shrimp
9.2.2 Heparin vs. Novel Oral Anticoagulants
9.2.3 Unmet Needs in Brazil and Worldwide
9.2.4 Trends in the Antithrombotic Drug Market
10. Conclusions from Our Study
10.1 The World Market for Antithrombotic Drugs 2015-2025
10.1.1 The Decline of Antiplatelet Drugs and the Rise of the Anticoagulants
10.2 The Leading National Markets 2015-2025
10.3 Trends in the Industry
10.3.1 The Market Will Recover From Plavix Decline
10.3.2 The Demand for Antithrombotic Drugs is Increasing Worldwide
10.3.3 Many Drugs Will Face Generic Competition Over the Coming 10 Years
10.3.4 High Barriers to Market Entry and a Limited Pipeline – The Implications
【レポート販売概要】
■ タイトル：抗血栓薬の世界市場：抗凝固薬、抗血小板薬■ 英文：Antithrombotic Drugs: World Industry and Market Prospects 2015-2025
■ 発行日：2015年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN5040808
■ 調査対象地域：グローバル
- グローバルにおける空気圧モーターおよびエンジン市場（～2019）The industry report Global Pneumatic Power Motor and Engine Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for pneumatic power motors and engines in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for indu …
- ドイツの手術室用装置市場見通し（～2021）Germany Operating Room Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Germany Operating Room Equipment Market Outlook to 2021", provides key market data on the Germany Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Operating Room Tables, Operating Room Ligh …
- ガスハイドレート（ガス水和物）の市場性分析：Analyzing the Potential of Gas HydratesA gas hydrate is a crystalline solid; its building blocks consist of a gas molecule surrounded by a cage of water molecules. Thus it is similar to ice, except that the crystalline structure is stabilized by the guest gas molecule within the cage of water molecules. Many gases have molecular sizes suitable to form hydrate, including such naturally occurring gases as carbon dioxide, hydrogen sulfide …
- 集団健康管理（PHM）の世界市場：ソフトウェア、サービスThe global population health management market is segmented on the basis of component, delivery mode, and end-user. By component, the market is categorized into software and services. In 2015, the software segment accounted for the larger share of the PHM market and expected to grow at the fastest rate during the forecast period. The market is divided on the basis of delivery mode into web-based, …
- Hugoton Royalty Trust：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Hugoton Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Hugoton Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- マイクロカプセル化の世界市場の予測＆動向分析：用途別（医薬品、家庭用製品、農薬、食品添加物、相変化材料）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、RoW）、セグメント予測、2014 – 2025The global microencapsulation market is expected to reach USD 17.94 billion by 2025, according to a new report by Grand View Research, Inc. The ability of the technology to allow incorporation of minerals, vitamins, flavors and essential oils in food products to improve its nutritional value is likely to propel demand. Availability of raw materials such as sodium alginate, gelatin and PVA is a maj …
- OMV Aktiengesellschaft：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013OMV Aktiengesellschaft Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary OMV Aktiengesellschaft Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 抗菌プラスチックの世界市場予測Antimicrobial plastic are polymers which are mainly used to reduce or restrain the growth of microorganisms such as algae, bacteria, and fungi on any plastic products to maintain hygiene and increase its shelf life. Antimicrobial plastic are used in a variety of applications ranging from health care, construction, packaging containers to consumer goods, and automotive parts. Health care is the lar …
- 生物製剤コールドチェーン包装の世界市場About biopharmaceutical cold chain packaging Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These prod …
- 世界のホジキンリンパ腫治療/医薬品市場（2014-2018）About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. …
- 動脈狭窄症(Artery Stenosis)：世界の治験レビュー（2015年上半期版）Artery Stenosis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Artery Stenosis Global Clinical Trials Review, H1, 2015" provides data on the Artery Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Artery Stenosis. It includes an overview of the trial numbers and their recruitment status as …
- 世界の多重パラメーター患者モニタリング装置市場動向（2012-2016）TechNavio's analysts forecast the Global Multiparameter Patient Monitoring Equipment market to grow at a CAGR of 3.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growth in aging population. The Global Multiparameter Patient Monitoring Equipment market has also been witnessing technological advancements. However, the high price and low accurac …
- 原子炉建設の世界市場2015-2019About Nuclear Reactors Nuclear reactors find application in the nuclear plants for generating electricity and propelling ships. As of February 2015, nuclear power plants accounted for 11 percent of the total electricity production globally. Currently, there are 437 nuclear reactors present across 48 countries, and 64 reactors under construction. A majority of the new reactors are being planned for …
- ICT調達動向：大企業部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which large enterprises select their ICT providers as well as the roles which have influence while making ICT purchasing decisions. What is the current market landscape and what is changing? Large enterprises exhibit a clear preference for deploying technologies on-site compared to as a hosted service. However, preference towards hosted depl …
- 産業用保護手袋の世界市場2017-2021About Industrial Safety Glove Gloves are a form of personal protective equipment for hand and arms. Industrial safety gloves are mainly employed by workforce in industrial ecosystems. The factors driving this market include the global increase in rubber production, mainly in Malaysian region. Furthermore, the growth in various industrial segments have a positive impact on the market. The occupatio …
